In April 2026, Tempus AI, Inc., the Keck School of Medicine of USC, and Keck Medicine of USC announced a multi-faceted collaboration to embed Tempus’ AI-enabled molecular diagnostics, clinical trial ...
Source LinkIn April 2026, Tempus AI, Inc., the Keck School of Medicine of USC, and Keck Medicine of USC announced a multi-faceted collaboration to embed Tempus’ AI-enabled molecular diagnostics, clinical trial ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.